Literature DB >> 17421078

Tumor vascular area correlates with photosensitizer uptake: analysis of verteporfin microvascular delivery in the Dunning rat prostate tumor.

Xiaodong Zhou1, Bin Chen, P Jack Hoopes, Tayyaba Hasan, Brian W Pogue.   

Abstract

The parameters that limit supply of photosensitizer to the cancer cells in a solid tumor were systematically analyzed with the use of microvascular transport modeling and histology data from frozen sections. In particular, the vascular permeability transport coefficient and the effective interstitial diffusion coefficient were quantified for Verteporfin-for-Injection delivery of benzoporphyrin derivative (BPD). Orthotopic tumors had higher permeability and diffusion coefficients (Pd = 0.036 microm/s and D = 1.6 microm(2)/s, respectively) as compared to subcutaneously grown tumors (Pd = 0.025 microm/s and D = 0.9 microm2/s, respectively), likely due to the fact that the vessel patterns are more homogeneous orthotopically. In general, large intersubject and intratumor variability exist in the verteporfin concentration, in the range of 25% in plasma concentration and in the range of 20% for tissue concentrations, predominantly due to these microregional variations in transport. However, the average individual uptake of photosensitizer in tumor tissue was only correlated to the total vascular area within the tumor (R2 = 64.1%, P < 0.001). The data are consistent with a view that microregional variation in the vascular permeability and interstitial diffusion rate contribute the spatial heterogeneity observed in verteporfin uptake, but that average supply to the tissue is limited by the total area of perfused blood vessels. This study presents a method to systematically analyze micro-heterogeneity as well as possible methods to increase delivery and homogeneity of photosensitizer within tumor tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17421078     DOI: 10.1562/2006-03-25-ra-858

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  6 in total

1.  Tumor vascular microenvironment determines responsiveness to photodynamic therapy.

Authors:  Amanda L Maas; Shirron L Carter; E Paul Wileyto; Joann Miller; Min Yuan; Guoqiang Yu; Amy C Durham; Theresa M Busch
Journal:  Cancer Res       Date:  2012-02-28       Impact factor: 12.701

2.  Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700-antibody conjugates.

Authors:  Shun Kishimoto; Marcelino Bernardo; Keita Saito; Sho Koyasu; James B Mitchell; Peter L Choyke; Murali C Krishna
Journal:  Free Radic Biol Med       Date:  2015-04-08       Impact factor: 7.376

Review 3.  Biomodulatory approaches to photodynamic therapy for solid tumors.

Authors:  Sanjay Anand; Bernhard J Ortel; Stephen P Pereira; Tayyaba Hasan; Edward V Maytin
Journal:  Cancer Lett       Date:  2012-07-25       Impact factor: 8.679

4.  High dose rate radiation treatment of experimental intramuscular prostate carcinoma.

Authors:  Christina Skourou; P Jack Hoopes; Summer L Gibbs-Strauss; David J Gladstone; Rendall Strawbridge; Keith D Paulsen
Journal:  Int J Radiat Biol       Date:  2009-04       Impact factor: 2.694

5.  Focal treatment of prostate cancer with vascular-targeted photodynamic therapy.

Authors:  Scott E Eggener; Jonathan A Coleman
Journal:  ScientificWorldJournal       Date:  2008-10-03

6.  Characterization of Perturbing Actions by Verteporfin, a Benzoporphyrin Photosensitizer, on Membrane Ionic Currents.

Authors:  Mei-Han Huang; Ping-Yen Liu; Sheng-Nan Wu
Journal:  Front Chem       Date:  2019-08-22       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.